Forgot Password?
Return to Course Listing

CME: Critical Care Pharmacotherapy Literature Update - (April 2012)

ACCREDITATION EXPIRED: April 24, 2014

Activity Description / Statement of Need:

In this online CME self-learning program:

This is a monthly review of select articles in the medical literature pertaining to pharmacotherapy used in
critically ill patient populations. The content below is for information purposes only and is intended to
highlight recent articles that may be of interest to those caring for patients in various intensive care or
related settings. Though some core content from the publications is presented, the reader is encouraged
to review each article in full for additional detail in order to fully interpret the study, its findings, and its
applicability to practice.

Target Audience:

This program has been designed for a multidisciplinary physician, nurse, and pharmacist audience including: ICU / Anesthesia / Peri-op / Intensivists / Trauma / Critical Care

This program is NOT supported by any commercial support.

Release Date: April 24, 2012 -- Expiration Date: April 24, 2014

Faculty: Charles Turck, PharmD, BCPS

Agenda

Learning Objectives

By the end of the session the participant will be able to:

  • Be able to describe the study: DEXMEDTOMIDINE VS MIDAZOLAM OR PROPOFOL FOR SEDATION DURING PROLONGED MECHANICAL VENTILATION
  • Be able to describe the study: ASSOCIATION BETWEEN INHALED NITRIC OXIDE TREATMENT AND LONG-TERM PULMONARY FUNCTION IN SURVIVORS OF ACUTE RESPIRATORY DISTRESS SYNDROME
  • Be able to describe the study: WHAT IS THE EFFICACY AND SAFETY OF COLISTIN FOR THE TREATMENT OF VENTILATOR-ASSOCIATED PNEUMONIA? A SYSTEMATIC REVIEW AND META-REGRESSION
  • Be able to describe the study: REPLACEMENT OF FENTANYL INFUSION BY ENTERAL METHADONE DECREASES THE WEANING TIME FROM MECHANICAL VENTILATION: A RANDOMIZED CONTROLLED TRIAL
  • Be able to describe the study: LINEZOLID IN METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS NOSOCOMIAL PNEUMONIA: A RANDOMIZED, CONTROLLED STUDY

Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through ScientiaCME. ScientiaCME is accredited by the ACCME to provide continuing medical education for physicians.

 

Credit Designation: ScientiaCME designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™ toward the AMA Physician's Recognition Award. Physicians should only claim credit commensurate with the extent of their participation in the activity.

 

ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.


Faculty Disclosure and Resolution of COI

As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.

 

Disclosures of Faculty / Educational Planners: Charles Turck, PharmD is an officer and part owner of ScientiaCME, LLC. ScientiaCME has received grants from Bayer, Edwards Lifesciences, Eisai, Daiichi-Sankyo, Lilly, Merck, Pfizer, Sanofi Aventis.

 

Commercial Support Disclosure: This program is NOT supported by any commercial support.

 

Unlabled Use Disclosure: This program may contain unlabled and/or investigational uses of a commercial product

Instructions

  • Read the learning objectives above
  • Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowledge gained by participating in this CME activity.
  • View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
  • Minimum participation threshold: Take the post-test. A score of 70% or higher is required to pass and proceed to the activity evaluation.
  • Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.

Cultural/Linguistic Competence & Health Disparities

System Requirements

PC
Windows 7 or above
Internet Explorer 8
*Adobe Acrobat Reader
MAC
Mac OS 10.2.8
Safari or Chrome or Firefox
*Adobe Acrobat Reader
Internet Explorer is not supported on the Macintosh

*Required to view Printable PDF Version

Perform Pre-Test (optional)

Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.